Antimicrobial resistance (AMR) causes over 35,000 deaths annually in the EU/EEA and is projected to result in 1.91 million ...

According to GSK, the programme of 'Grand Challenge' research projects will make use of AI and other cutting-edge ...

GSK funding allocated to six new research programmes which will combine expertise and using cutting edge AI technology to ...

In the second part of this series, we show how frontline medics are fighting for a future where routine infections do not ...

Antimicrobial peptides can control Salmonella infections in chickens and, thus, have the potential to improve food safety and public health, according to a new study. The study was published in ...

Data highlighting potential of Nu-3 in mildly infected diabetic foot ulcer (iDFU) published in "Antimicrobial Agents and Chemotherapy" "This peer-reviewed paper underscores the unique potential of ...

A honeybee hive, with its large stores of pollen, wax, and honey, is like a fortress guarding treasure: with strong defenses, but a bonanza for enemies that can overcome those. More than 30 parasites ...

Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity against some of the world's ...

Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new small-molecule drug class. The pact’s potential value includes an undisclosed ...

Researchers looked specifically at head-to-head randomized clinical trials of next-in-class cancer drugs against existing agents in the same class. Less than one-quarter of next-in-class cancer drugs ...

Antimicrobial resistance (AMR) is one of the most urgent public health challenges in 2025. This phenomenon occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve resistance ...